Prior authorization delays leave neurology patients without timely treatment, new AMA data show
Neurologists spend an average of 13 hours a week on prior authorization requests, a burden that the American Medical Association says delays necessary care for 95% of physicians’ patients and drives treatment abandonment in nearly 80% of cases.
Dr. Bruce Cohen, a pediatric neurologist in Akron, Ohio, and chair of the American Academy of Neurology (AAN) Advocacy Committee, said the paperwork pulls him away from patient care for conditions such as multiple sclerosis and migraine where delays can cause irreversible progression. “In nearly all instances, the items requested meet the prior authorization request, as it exists already in the medical record,” Cohen told Medscape. Matt Kerschner, the AAN’s director of regulatory affairs and policy, said the problem extends beyond Medicare Advantage into employer-sponsored plans that impose step-therapy requirements. “We know this can lead to irreversible disease progression as well as a number of adverse outcomes, including increased hospitalizations, emergency department visits, and disability,” Kerschner told Medscape. The AMA’s most recent survey found practices complete an average of 40 prior authorization requests per physician each week, up from 29.1 per week in the association’s 2017 survey, which also reported 14.6 hours of staff time per physician. The earlier data showed 64% of practices waited at least one business day for a decision and 30% waited three or more days, according to Practical Neurology. Disparate impact on neurology patients with limited digital access, limited English proficiency, cognitive impairment, or caregiver constraints — all common in neurology — face disproportionate barriers, Cohen said. Burnout and workforce strain
Ninety-four percent of physicians report that prior authorization increases burnout, the AMA data show. Cohen said peer-to-peer reviews with insurance physicians almost always result in approval, making the process a “waste of my time” when the clinical rationale is already documented. Federal and state legislative push
The AAN is backing two federal bills.
The Improving Seniors’ Timely Access to Care Act would impose guardrails on Medicare Advantage prior authorization, including electronic submission and faster response times. The legislation cleared the House Ways and Means and Energy and Commerce committees unanimously and advocates hope it will be included in a year-end package. The Safe Step Act would create commonsense exceptions to step-therapy protocols in employer-based plans, allowing patients to bypass a required failure on a less effective drug when the physician’s original choice is clinically appropriate. At the state level, the AAN has pushed reforms that mirror federal proposals and has focused on restricting the use of artificial intelligence in utilization management. “We are going to continue to fight to make sure that there are robust guardrails in place so that insurers cannot inappropriately use AI to inappropriately deny care,” Kerschner told Medscape.
AI as a potential tool for physicians
Cohen said AI could reduce administrative burden if applied to the provider side. “AI can sniff through the chart in a microsecond, looking for the questions that I would have to get on the phone to provide,” he told Medscape. The answers needed for approval are already in the record, he said, and automated extraction could accelerate decisions.
How neurologists can engage
The AAN’s Advocacy Action Center allows neurologists to send letters to their senators and representatives supporting both bills before the current Congress adjourns. The academy also organizes “Neurology on the Hill” each winter, bringing roughly 200 neurologists to Washington, and “Neurology off the Hill” in August for district-office meetings. What happens next
The Improving Seniors’ Timely Access to Care Act awaits floor action in the House and Senate. The Safe Step Act has been referred to committee.
Related reading